Barrington Research Cuts U.S. Physical Therapy (NYSE:USPH) Price Target to $98.00

U.S. Physical Therapy (NYSE:USPH) had its target price decreased by Barrington Research from $108.00 to $98.00 in a research note issued to investors on Friday morning,Benzinga reports. Barrington Research currently has an outperform rating on the stock.

USPH has been the topic of several other research reports. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $100.00 to $115.00 in a report on Monday, December 16th. JPMorgan Chase & Co. boosted their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. JMP Securities assumed coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target on the stock. Finally, William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $111.50.

U.S. Physical Therapy Price Performance

Shares of NYSE:USPH opened at $81.08 on Friday. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63. The firm has a market capitalization of $1.22 billion, a PE ratio of 86.26, a PEG ratio of 3.54 and a beta of 1.48. The business’s 50 day moving average is $88.41 and its 200-day moving average is $87.67. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. Sell-side analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is 95.65%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Several institutional investors have recently bought and sold shares of USPH. Creative Planning bought a new position in U.S. Physical Therapy in the 3rd quarter valued at $252,000. International Assets Investment Management LLC raised its position in shares of U.S. Physical Therapy by 8,414.8% during the third quarter. International Assets Investment Management LLC now owns 2,299 shares of the company’s stock worth $195,000 after acquiring an additional 2,272 shares during the last quarter. Cambiar Investors LLC raised its position in shares of U.S. Physical Therapy by 31.3% during the third quarter. Cambiar Investors LLC now owns 26,655 shares of the company’s stock worth $2,256,000 after acquiring an additional 6,350 shares during the last quarter. Harbor Capital Advisors Inc. raised its position in shares of U.S. Physical Therapy by 113.4% during the third quarter. Harbor Capital Advisors Inc. now owns 16,188 shares of the company’s stock worth $1,370,000 after acquiring an additional 8,604 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in shares of U.S. Physical Therapy by 1.0% during the third quarter. Principal Financial Group Inc. now owns 79,817 shares of the company’s stock worth $6,755,000 after acquiring an additional 766 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.